Another partner in the DevelopAKUre consortium is the Laboratory of Genetics that originally belonged to the Institute of Molecular Physiology and Genetics of Slovak Academy of Sciences (SAV). In May 2015 this group moved to the Center for Molecular Medicine of SAS (http://www.sav.sk/index.php?l.. ...more
Last week the DevelopAKUre consortium attended the 9th international workshop on AKU in Copenhagen. It was the one-year anniversary of AKU patient Robert Gregory’s death and we started the day by remembering Robert and all that he achieved for AKU patients. Robert was a massive driving for.. ...more
One of our partners in the DevelopAKUre consortium is an organisation called PSR Orphan Experts. PSR Orphan Experts (http://www.orphandrugexperts.com/site/home/) are located in Hoofddorp, the Netherlands, and are currently working on the SONIA 2 clinical trial. Their team consists of one Project.. ...more
Our research group is led by Prof. Annalisa Santucci and is located within the University of Siena (http://en.unisi.it/), Department of Biotechnology, Chemistry and Pharmacy. We are one of the three Academic members of the DevelopAKUre Consortium. We have great expertise in the study of proteins rel.. ...more
DevelopAKUre is a series of major international clinical trials, run by a consortium of 12 European partners. It aims to study a potential new drug, called nitisinone, and assess its potential effectiveness in treating the rare disease, alkaptonuria (AKU).
DevelopAKUre is co-funded by a grant from the European Commission. This website is run by a UK patient group, the AKU Society. Learn more about AKU on the AKU Society's What is AKU page.
In today’s blog Chief investigator Prof. Ranganath reinforces the need for SONIA 2 pat.. ...more